Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma

  • Rafee Talukder
  • , Dimitra Rafailia Bakaloudi
  • , Dimitrios Makrakis
  • , Leonidas N. Diamantopoulos
  • , Thomas Enright
  • , Jacob B. Leary
  • , Ruben Raychaudhuri
  • , Nishita Tripathi
  • , Neeraj Agarwal
  • , Tanya Jindal
  • , Jason R. Brown
  • , Yousef Zakharia
  • , Macarena Rey-Cárdenas
  • , Daniel Castellano
  • , Charles B. Nguyen
  • , Ajjai Alva
  • , Roubini Zakopoulou
  • , Aristotelis Bamias
  • , Rafael Morales Barrera
  • , David Marmolejo
    • Alexandra Drakaki, David J. Pinato, James Korolewicz, Lucia Alonso Buznego, Ignacio Duran, Clara Castro Carballeira, Rana R. McKay, Tyler F. Stewart, Shilpa Gupta, Pedro Barata, Evan Y. Yu, Vadim S. Koshkin, Ali Raza Khaki, Petros Grivas

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Fingerprint

Entra nei temi di ricerca di 'Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma'. Insieme formano una fingerprint unica.
Ordina per

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology